Metrikler
Yayın
45
Açık Erişim
8
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2017 - Devam Ediyor
2017 - Devam EdiyorTıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2012 - 2016
2012 - 2016Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2004 - 2010
2004 - 2010Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Türkiye
Makaleler
Tümü (35)
SCI-E, SSCI, AHCI (29)
SCI-E, SSCI, AHCI, ESCI (33)
ESCI (4)
Scopus (32)
TRDizin (4)
Diğer Yayınlar (1)
2025
20251. Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical tiral
Akgoz A., Yakut Y., Tufekci O., AKTAŞ B. Y., Sari E. O., Barlak A., et al.
RHEUMATOLOGY INTERNATIONAL
, cilt.45, sa.9, 2025 (SCI-Expanded, Scopus)
2024
20242. Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer
YILMAZ F., YAŞAR S., Tatar O. D., Yildirim H. C., Guven D. C., AKYILDIZ A., et al.
BMC CANCER
, cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)
2024
20243. Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)
YAŞAR H. A., AKTAŞ B. Y., Ucar G., SEZGİN GÖKSU S., Bilgetekin I., Cakar B., et al.
Clinical Genitourinary Cancer
, cilt.22, sa.3, 2024 (SCI-Expanded, Scopus)
2024
20244. Vaccination attitudes and practices of physicians and nurses in adult oncology settings
Ozdemir-Ayduran N., AKTAŞ B. Y., KILIÇKAP S., EKİNCİOĞLU A.
JOURNAL OF RESEARCH IN PHARMACY
, cilt.28, sa.3, ss.612-620, 2024 (ESCI, Scopus, TRDizin)
2023
20235. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.
Current Oncology
, cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded, Scopus)
2023
20236. Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?
GÜNER G., AKTAŞ B. Y., Başal F. B., DEMİRKAZIK A., Gürsoy P., Demirci U., et al.
Journal of Cancer Research and Clinical Oncology
, cilt.149, sa.14, ss.13271-13277, 2023 (SCI-Expanded, Scopus)
2023
20237. Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy
GÜVEN D. C., Incesu F. G. G., YILDIRIM H. Ç., Erul E., Chalabiyev E., AKTAŞ B. Y., et al.
INTERNATIONAL JOURNAL OF CANCER
, cilt.152, ss.679-685, 2023 (SCI-Expanded, Scopus)
2023
20238. Emerging treatment strategies in hepatobiliary cancer
GÜVEN D. C., YILDIRIM H. Ç., Chalabiyev E., KUŞ F., YILMAZ F., YAŞAR S., et al.
Expert Review of Anticancer Therapy
, cilt.23, sa.3, ss.243-256, 2023 (SCI-Expanded, Scopus)
2022
20229. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience
DEMİR M., Guven D., AKTAŞ B. Y., GÜNER G., AKTEPE O. H., TABAN H., et al.
SOUTH ASIAN JOURNAL OF CANCER
, cilt.11, ss.287-292, 2022 (ESCI, Scopus)
2022
202210. Liquid biopsy markers for early diagnosis of brain metastasis patients with breast cancer by metabolomics
Ozer O., NEMUTLU E., REÇBER T., Eylem C. C., AKTAŞ B. Y., KIR S., et al.
EUROPEAN JOURNAL OF MASS SPECTROMETRY
, cilt.28, sa.1-2, ss.56-64, 2022 (SCI-Expanded, Scopus)
2022
202211. Pazopanib-induced chylothorax in a patient with renal cell carcinoma
KÖYLÜ B., TEKİN F., AKTAŞ B. Y., KILIÇKAP S., KÖKSAL D.
ANTI-CANCER DRUGS
, cilt.33, sa.1, 2022 (SCI-Expanded, Scopus)
2022
202212. Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy
YILDIRIM H. Ç., GÜVEN D. C., AKTEPE O. H., TABAN H., YILMAZ F., YAŞAR S., et al.
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY
, cilt.6, sa.1, ss.59-63, 2022 (ESCI, TRDizin)
2022
202213. Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.
FUTURE ONCOLOGY
, cilt.18, ss.323-331, 2022 (SCI-Expanded, Scopus)
2021
202114. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors
GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.
BIOMARKERS IN MEDICINE
, cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded, Scopus)
2021
202115. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Bilgin B., Sendur M. A. N., Yucel S., Celik E., Ozyukseler D. T., Ayhan M., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
, cilt.147, sa.7, ss.2145-2152, 2021 (SCI-Expanded, Scopus)
2021
202116. Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?
Sari S. Y., AKTAŞ B. Y., KERTMEN N., ELMALI A., Kilickap S., Oguz K. K., et al.
CUREUS
, cilt.13, sa.6, 2021 (ESCI)
2021
202117. The temporal evaluation of RAS and BRAF mutation by liquid biopsy at progression after bevacizumab combinations in patients with metastatic colorectal cancer (mCRC).
Bilgetekin I., Dogan M., Karacin C., Basal F. B., Esin E., Ucar G., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.39, sa.15, 2021 (SCI-Expanded, Scopus)
2021
202118. Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis
Akbulut D., Yuksel S., Kircali E., AKTAŞ B. Y., Kaygusuz G., Saglam A., et al.
LABORATORY INVESTIGATION
, cilt.101, ss.796-797, 2021 (SCI-Expanded, Scopus)
2021
202119. Immune Checkpoint Molecule (PD-1, PD-L1, PD-L2) Expression, 9p24.1 Gene Locus Alterations and Tumor Microenvironment Status of Primary Central Nervous System Lymphoma and Their Clinical Relevance: A Quantitative Analysis
Akbulut D., Yuksel S., Kircali E., AKTAŞ B. Y., Kaygusuz G., Saglam A., et al.
MODERN PATHOLOGY
, cilt.34, ss.796-797, 2021 (SCI-Expanded, Scopus)
2021
202120. Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience
Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., Olgun P., et al.
CANCER RESEARCH
, cilt.81, sa.4, 2021 (SCI-Expanded, Scopus)
2020
202021. Cancer incidence in Behcet's disease
GÜVEN D. C., BÖLEK E. Ç., ALTINTOP S. E., ÇELİKTEN B., AKTAŞ B. Y., KİRAZ S., et al.
IRISH JOURNAL OF MEDICAL SCIENCE
, cilt.189, sa.4, ss.1209-1214, 2020 (SCI-Expanded, Scopus)
2020
202022. Defining the Optimal Regimen for Stage III Colon Cancer: Concerns with Study Design
GÜVEN D. C., GÜNER G., AKTAŞ B. Y., AKTEPE O. H., TABAN H., ARIK Z.
CLINICAL COLORECTAL CANCER
, cilt.19, sa.3, 2020 (SCI-Expanded, Scopus)
2020
202023. Cancer incidence in Behcet's Disease.
Guven D. C., Bolek E. C., Altintop S. E., Celikten B., Aktas B. Y., Kiraz S., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)
2020
202024. Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey.
Basaran G., Demirci U., Yildiz F., Cicin I., Aktas B. Y., Ozturk B., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)
2020
202025. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications
GÜVEN D. C., AKTAŞ B. Y., ŞİMŞEK C., AKSOY S.
FUTURE ONCOLOGY
, cilt.16, sa.9, ss.497-506, 2020 (SCI-Expanded, Scopus)
2020
202026. Complete responses to two different anti-PD1 agents in a metastatic melanoma patient
KILIÇKAP S., GÜVEN D. C., AKTEPE O. H., AKTAŞ B. Y., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.2, ss.496-499, 2020 (SCI-Expanded, Scopus)
2019
201927. Vitamin D Supplementation and Prevention of Type 2 Diabetes
AKTAŞ B. Y., Aktas O. O.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.381, sa.18, ss.1784, 2019 (SCI-Expanded, Scopus)
2019
201928. Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy
AKTAŞ B. Y., Guner G., Guven D. C., Arslan C., DİZDAR Ö.
EXPERT REVIEW OF ANTICANCER THERAPY
, cilt.19, sa.7, ss.589-601, 2019 (SCI-Expanded, Scopus)
2019
201929. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behcet Disease With Tocilizumab
İLBAY A., ERDEN A., SARI A., ARMAĞAN B., AKTAŞ B. Y., BÖLEK E. Ç., et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
, cilt.25, sa.4, 2019 (SCI-Expanded, Scopus)
2019
201930. Evaluation of cancer risk in patients with periodontal diseases
Guven D. C., DİZDAR Ö., AKMAN A. C., Berker E., Yekeduz E., Ceylan F., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.3, ss.826-831, 2019 (SCI-Expanded, Scopus, TRDizin)
2018
201831. Mortality Facts in Internal Medicine Wards: A Descriptive Study froma University Hospital
ÇALIK BAŞARAN N., AKTAŞ B. Y., ŞENER Y. Z., CEYLAN S., YEKEDÜZ E., BAŞPINAR B., et al.
Acta Medica
, cilt.49, sa.4, ss.6-13, 2018 (TRDizin)
2017
201732. Impact of Exopolysaccharides (EPSs) of Lactobacillus gasseri strains isolated from human vagina on cervical tumor cells (HeLa).
SUNGUR T., ASLIM B., Karaaslan C., AKTAS B. Y.
Anaerobe
, cilt.47, ss.137-144, 2017 (SCI-Expanded, Scopus)
2015
201533. Cytomegalovirus (CMV) Infections in Patients with Rheumatic Diseases: Experience of a Referral Center
ŞENER Y. Z., AKTAŞ B. Y., Erden A., KILIÇ L., Armagan B., İNKAYA A. Ç., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2015
201534. Fatigue May be Independently Active at a Certain Part of Spondyloarthritis Patients: Hur-BIO Real Life Results
KALYONCU U., Erden A., KILIÇ L., Seyhoglu E., Guven D. C., AKTAŞ B. Y., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded, Scopus)
2014
201435. Kliniko-patolojik olgu tart›flmas›:Sistemik lupus eritematosus
AKTAŞ B. Y., KALYONCU U., İNKAYA A. Ç., TUNCER M. A., ARSAVA E. M., KARLI OĞUZ H. K.
RAED dergisi , cilt.6, sa.1, ss.36-41, 2014 (Hakemli Dergi)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. Clinicopathologic features of BRCA mutated breast cancer patients: Hacettepe experience
AKSOY S., DEĞİRMENCİLER R. F., AKTAŞ B. Y., Guven D. C., AKTEPE O. H., Guner G., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri)
2019
20192. Embedded outpatient palliative care service within the oncology clinic: Preliminary experience in Hacettepe Oncology Hospital
Guven D. C., AKTEPE O. H., Berk Z., Guner G., Taban H., AKTAŞ B. Y., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, (Özet Bildiri)
2019
20193. Clinical features and prognosis of patients with liposarcoma: Single-center experience.
Demir M., Guven D. C., Aktas B. Y., Guner G., Aktepe O. H., Taban H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)
2018
20184. Metastatic Choroidal Melanoma: Single Center Experience
AKTAŞ B. Y., GÜNER G., DEMİR M., GÜVEN D. C., AKTEPE O. H., BÖLEK E. Ç., et al.
2. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Türkiye, 31 Ekim - 04 Kasım 2018, ss.1-48, (Tam Metin Bildiri)
2018
20185. Evaluation of cancer risk in patients with periodontal diseases.
GÜVEN D. C., DİZDAR Ö., AKMAN A. C., BERKER A. E., YEKEDÜZ E., CEYLAN F., et al.
2018 ASCO Annual Meeting, Chicago, Amerika Birleşik Devletleri, 1 - 05 Haziran 2018, cilt.36, ss.13571, (Özet Bildiri)
2018
20186. TÜRKIYE’DE METASTATIK MEME KANSERINDE HER2 HEDEFLITEDAVIDE PERTUZUMAB KULLANIMI ERKEN DÖNEM GÜVENLILIKVERILERI
ESİN E., ÇAKMAK ÖKSÜZOĞLU Ö. B., SAKİN A., YILDIRIM N., ÇABUK D., KARAAĞAÇ M., et al.
7. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Türkiye, 21 - 24 Mart 2018, (Özet Bildiri)
2017
20177. Retrospektive investigation of sepsis related inpatient mortality
AKTAŞ B. Y., ÇALIK BAŞARAN N., ŞENER Y. Z., BÖLEK E. Ç., ÖZTÜRK AKTAŞ ö., ÖZIŞIK L., et al.
16th European Congress of Internal Medicine, 31 Ağustos - 02 Eylül 2017, (Özet Bildiri)
2017
20178. Retrospective Investigation of sepsis related inpatient mortality
AKTAŞ B. Y., ÇALIK BAŞARAN N., ŞENER Y. Z., BÖLEK E. Ç., öztürk aktaş ö., ÖZIŞIK L., et al.
ECIM, 31 Ağustos - 02 Eylül 2017, (Özet Bildiri)
2017
20179. Smoker relatives of inpatients: A reasonable but heterogeneous target population for smoking cessation program
AKTAŞ B. Y., HOUSSEİN b., YÜCE D., DİZDAR Ö., KILIÇKAP S., ERMAN M., et al.
7th ECTOH Conference on Tobacco or Health, Porto, Portekiz, 22 - 25 Mart 2017, (Özet Bildiri)
Kitaplar
2017
20171. PATOFİZYOLOJİNİN TEMELLERİ
DURUSU TANRIÖVER M., SARI A., EŞME M., KOÇ YILDIRIM S., YILDIRIM M. Ş., BÖLEK E. Ç., et al.
PALME YAYINCILIK, 2017